📰 Evercore Group News
Page 33 - Evercore Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evercore Group. Real-time updates on events, politics, business and more.
February 3, 2021
CCC Information Services Going Public in $7 Billion Blank Check Transaction By Niket Nishant | February 3, 2021 CCC Information Services said on Wednesday it was going public through a merger with blank-check firm Dragoneer Growth Opportunities Corp., in a deal valuing the data and technology provider to automotive and insurance companies at about $7 billion. The deal is expected to fetch CCC Information $968 million in proceeds, including a $150 million priv...
February 3, 2021
Insurance Tech Firm CCC Information to Go Public Via $7B SPAC Deal February 3, 2021 CCC Information Services said on Wednesday it was going public through a merger with blank-check firm Dragoneer Growth Opportunities Corp, in a deal that valued the data and technology provider to auto and insurance firms at about $7 billion. The deal is expected to fetch CCC Information $968 million, including a $150 million private investment from Fidelity Investments, T. Ro...
February 3, 2021
2 months ago Transaction includes $150 million of fully committed common stock PIPE with participation by Fidelity Investments, funds and accounts advised by T. Rowe Price Associates, Inc. and other investors, in addition to $175 million forward purchase agreement from Dragoneer funds and Michael Bloomberg’s family office, Willett Advisors $968 million of expected net proceeds from transaction will be used to invest in CCC’s growth initiatives and for general...
February 2, 2021
Press release content from Accesswire. The AP news staff was not involved in its creation. CureVac Announces Closing of $450 million Follow-on Public Offering of Common Shares February 2, 2021 GMT TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / February 2, 2021 / CureVac N.V. (Nasdaq:CVAC) (“CureVac” or the “Company”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announced today the closing of it...
January 28, 2021
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 28, 2021 / CureVac N.V. (Nasdaq: CVAC) ("CureVac" or the "Company"), a global biopharmaceutical company developing a new class of transformative
January 28, 2021
Press release content from Accesswire. The AP news staff was not involved in its creation.
January 28, 2021
DGAP-News: CureVac / Key word: Financing/Corporate Action CureVac Announces Pricing of USD450 million Follow-on Public Offering of Common Shares 2021-01-28 / 07:00 The issuer is solely responsible...
January 26, 2021
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 25, 2021 / CureVac N.V. (NASDAQ:CVAC) ("CureVac" or the "Company"), a global biopharmaceutical company developing a new class of transformative medicines
January 26, 2021
Press release content from Accesswire. The AP news staff was not involved in its creation. CureVac Announces Proposed Public Offering of Common Shares January 26, 2021 GMT TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 25, 2021 / CureVac N.V. (NASDAQ:CVAC) (“CureVac” or the “Company”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announced today that it intends to offer and sell in an un...
January 20, 2021
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the